Form 4: GoodRx Holdings Executive Scott Wagner Reports Stock Transactions
SEC Form 4
Scott Wagner, Interim CEO of GoodRx Holdings, reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units.
Summary
- On June 8, 2024, Scott Wagner, Interim CEO of GoodRx Holdings, reported transactions involving Class A Common Stock and Restricted Stock Units.
- Wagner acquired 70,591 shares of Class A Common Stock through the exercise of Restricted Stock Units.
- He also disposed of 35,776 shares of Class A Common Stock at a price of $8.55.
- Following these transactions, Wagner directly owns 80,219 shares of Class A Common Stock and indirectly owns 182,900 shares through the Wagner Family Trust.
- He also directly owns 423,549 Restricted Stock Units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting stock transactions by an executive. It doesn't inherently convey positive or negative sentiment.
Future Outlook
The restricted stock unit award will vest in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to continued employment.
Industry Context
This Form 4 filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to the market regarding the trading activities of company executives.
Key Dates
| Date | Description |
|---|---|
| 05/08/2024 | Beginning date for the monthly vesting of the restricted stock unit award. |
| 06/08/2024 | Date of the reported transactions involving Class A Common Stock and Restricted Stock Units. |
| 06/10/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.